- •CONTENTS
- •Preface
- •Contributors
- •1 Introduction to Toxicology
- •1.1 Definition and Scope, Relationship to Other Sciences, and History
- •1.1.2 Relationship to Other Sciences
- •1.1.3 A Brief History of Toxicology
- •1.3 Sources of Toxic Compounds
- •1.3.1 Exposure Classes
- •1.3.2 Use Classes
- •1.4 Movement of Toxicants in the Environment
- •Suggested Reading
- •2.1 Introduction
- •2.2 Cell Culture Techniques
- •2.2.1 Suspension Cell Culture
- •2.2.2 Monolayer Cell Culture
- •2.2.3 Indicators of Toxicity in Cultured Cells
- •2.3 Molecular Techniques
- •2.3.1 Molecular Cloning
- •2.3.2 cDNA and Genomic Libraries
- •2.3.3 Northern and Southern Blot Analyses
- •2.3.4 Polymerase Chain Reaction (PCR)
- •2.3.5 Evaluation of Gene Expression, Regulation, and Function
- •2.4 Immunochemical Techniques
- •Suggested Reading
- •3.1 Introduction
- •3.2 General Policies Related to Analytical Laboratories
- •3.2.1 Standard Operating Procedures (SOPs)
- •3.2.2 QA/QC Manuals
- •3.2.3 Procedural Manuals
- •3.2.4 Analytical Methods Files
- •3.2.5 Laboratory Information Management System (LIMS)
- •3.3 Analytical Measurement System
- •3.3.1 Analytical Instrument Calibration
- •3.3.2 Quantitation Approaches and Techniques
- •3.4 Quality Assurance (QA) Procedures
- •3.5 Quality Control (QC) Procedures
- •3.6 Summary
- •Suggested Reading
- •4 Exposure Classes, Toxicants in Air, Water, Soil, Domestic and Occupational Settings
- •4.1 Air Pollutants
- •4.1.1 History
- •4.1.2 Types of Air Pollutants
- •4.1.3 Sources of Air Pollutants
- •4.1.4 Examples of Air Pollutants
- •4.1.5 Environmental Effects
- •4.2 Water and Soil Pollutants
- •4.2.1 Sources of Water and Soil Pollutants
- •4.2.2 Examples of Pollutants
- •4.3 Occupational Toxicants
- •4.3.1 Regulation of Exposure Levels
- •4.3.2 Routes of Exposure
- •4.3.3 Examples of Industrial Toxicants
- •Suggested Reading
- •5 Classes of Toxicants: Use Classes
- •5.1 Introduction
- •5.2 Metals
- •5.2.1 History
- •5.2.2 Common Toxic Mechanisms and Sites of Action
- •5.2.3 Lead
- •5.2.4 Mercury
- •5.2.5 Cadmium
- •5.2.6 Chromium
- •5.2.7 Arsenic
- •5.2.8 Treatment of Metal Poisoning
- •5.3 Agricultural Chemicals (Pesticides)
- •5.3.1 Introduction
- •5.3.3 Organochlorine Insecticides
- •5.3.4 Organophosphorus Insecticides
- •5.3.5 Carbamate Insecticides
- •5.3.6 Botanical Insecticides
- •5.3.7 Pyrethroid Insecticides
- •5.3.8 New Insecticide Classes
- •5.3.9 Herbicides
- •5.3.10 Fungicides
- •5.3.11 Rodenticides
- •5.3.12 Fumigants
- •5.3.13 Conclusions
- •5.4 Food Additives and Contaminants
- •5.5 Toxins
- •5.5.1 History
- •5.5.2 Microbial Toxins
- •5.5.3 Mycotoxins
- •5.5.4 Algal Toxins
- •5.5.5 Plant Toxins
- •5.5.6 Animal Toxins
- •5.6 Solvents
- •5.7 Therapeutic Drugs
- •5.8 Drugs of Abuse
- •5.9 Combustion Products
- •5.10 Cosmetics
- •Suggested Reading
- •6 Absorption and Distribution of Toxicants
- •6.1 Introduction
- •6.2 Cell Membranes
- •6.3 Mechanisms of Transport
- •6.3.1 Passive Diffusion
- •6.4 Physicochemical Properties Relevant to Diffusion
- •6.4.1 Ionization
- •6.5 Routes of Absorption
- •6.5.1 Extent of Absorption
- •6.5.2 Gastrointestinal Absorption
- •6.5.3 Dermal Absorption
- •6.5.4 Respiratory Penetration
- •6.6 Toxicant Distribution
- •6.6.1 Physicochemical Properties and Protein Binding
- •6.7 Toxicokinetics
- •Suggested Reading
- •7 Metabolism of Toxicants
- •7.1 Introduction
- •7.2 Phase I Reactions
- •7.2.4 Nonmicrosomal Oxidations
- •7.2.5 Cooxidation by Cyclooxygenases
- •7.2.6 Reduction Reactions
- •7.2.7 Hydrolysis
- •7.2.8 Epoxide Hydration
- •7.2.9 DDT Dehydrochlorinase
- •7.3 Phase II Reactions
- •7.3.1 Glucuronide Conjugation
- •7.3.2 Glucoside Conjugation
- •7.3.3 Sulfate Conjugation
- •7.3.4 Methyltransferases
- •7.3.7 Acylation
- •7.3.8 Phosphate Conjugation
- •Suggested Reading
- •8 Reactive Metabolites
- •8.1 Introduction
- •8.2 Activation Enzymes
- •8.3 Nature and Stability of Reactive Metabolites
- •8.4 Fate of Reactive Metabolites
- •8.4.1 Binding to Cellular Macromolecules
- •8.4.2 Lipid Peroxidation
- •8.4.3 Trapping and Removal: Role of Glutathione
- •8.5 Factors Affecting Toxicity of Reactive Metabolites
- •8.5.1 Levels of Activating Enzymes
- •8.5.2 Levels of Conjugating Enzymes
- •8.5.3 Levels of Cofactors or Conjugating Chemicals
- •8.6 Examples of Activating Reactions
- •8.6.1 Parathion
- •8.6.2 Vinyl Chloride
- •8.6.3 Methanol
- •8.6.5 Carbon Tetrachloride
- •8.6.8 Acetaminophen
- •8.6.9 Cycasin
- •8.7 Future Developments
- •Suggested Reading
- •9.1 Introduction
- •9.2 Nutritional Effects
- •9.2.1 Protein
- •9.2.2 Carbohydrates
- •9.2.3 Lipids
- •9.2.4 Micronutrients
- •9.2.5 Starvation and Dehydration
- •9.2.6 Nutritional Requirements in Xenobiotic Metabolism
- •9.3 Physiological Effects
- •9.3.1 Development
- •9.3.2 Gender Differences
- •9.3.3 Hormones
- •9.3.4 Pregnancy
- •9.3.5 Disease
- •9.3.6 Diurnal Rhythms
- •9.4 Comparative and Genetic Effects
- •9.4.1 Variations Among Taxonomic Groups
- •9.4.2 Selectivity
- •9.4.3 Genetic Differences
- •9.5 Chemical Effects
- •9.5.1 Inhibition
- •9.5.2 Induction
- •9.5.3 Biphasic Effects: Inhibition and Induction
- •9.6 Environmental Effects
- •9.7 General Summary and Conclusions
- •Suggested Reading
- •10 Elimination of Toxicants
- •10.1 Introduction
- •10.2 Transport
- •10.3 Renal Elimination
- •10.4 Hepatic Elimination
- •10.4.2 Active Transporters of the Bile Canaliculus
- •10.5 Respiratory Elimination
- •10.6 Conclusion
- •Suggested Reading
- •11 Acute Toxicity
- •11.1 Introduction
- •11.2 Acute Exposure and Effect
- •11.3 Dose-response Relationships
- •11.4 Nonconventional Dose-response Relationships
- •11.5 Mechanisms of Acute Toxicity
- •11.5.1 Narcosis
- •11.5.2 Acetylcholinesterase Inhibition
- •11.5.3 Ion Channel Modulators
- •11.5.4 Inhibitors of Cellular Respiration
- •Suggested Reading
- •12 Chemical Carcinogenesis
- •12.1 General Aspects of Cancer
- •12.2 Human Cancer
- •12.2.1 Causes, Incidence, and Mortality Rates of Human Cancer
- •12.2.2 Known Human Carcinogens
- •12.3 Classes of Agents Associated with Carcinogenesis
- •12.3.2 Epigenetic Agents
- •12.4 General Aspects of Chemical Carcinogenesis
- •12.5 Initiation-Promotion Model for Chemical Carcinogenesis
- •12.6 Metabolic Activation of Chemical Carcinogens and DNA Adduct Formation
- •12.7 Oncogenes
- •12.8 Tumor Suppressor Genes
- •12.8.1 Inactivation of Tumor Suppressor Genes
- •12.8.2 p53 Tumor Suppressor Gene
- •12.9 General Aspects of Mutagenicity
- •12.10 Usefulness and Limitations of Mutagenicity Assays for the Identification of Carcinogens
- •Suggested Reading
- •13 Teratogenesis
- •13.1 Introduction
- •13.2 Principles of Teratology
- •13.3 Mammalian Embryology Overview
- •13.4 Critical Periods
- •13.5 Historical Teratogens
- •13.5.1 Thalidomide
- •13.5.2 Accutane (Isotetrinoin)
- •13.5.3 Diethylstilbestrol (DES)
- •13.5.4 Alcohol
- •13.6 Testing Protocols
- •13.6.1 FDA Guidelines for Reproduction Studies for Safety Evaluation of Drugs for Human Use
- •13.6.3 Alternative Test Methods
- •13.7 Conclusions
- •Suggested Reading
- •14 Hepatotoxicity
- •14.1 Introduction
- •14.1.1 Liver Structure
- •14.1.2 Liver Function
- •14.2 Susceptibility of the Liver
- •14.3 Types of Liver Injury
- •14.3.1 Fatty Liver
- •14.3.2 Necrosis
- •14.3.3 Apoptosis
- •14.3.4 Cholestasis
- •14.3.5 Cirrhosis
- •14.3.6 Hepatitis
- •14.3.7 Oxidative Stress
- •14.3.8 Carcinogenesis
- •14.4 Mechanisms of Hepatotoxicity
- •14.5 Examples of Hepatotoxicants
- •14.5.1 Carbon Tetrachloride
- •14.5.2 Ethanol
- •14.5.3 Bromobenzene
- •14.5.4 Acetaminophen
- •14.6 Metabolic Activation of Hepatotoxicants
- •Suggested Reading
- •15 Nephrotoxicity
- •15.1 Introduction
- •15.1.1 Structure of the Renal System
- •15.1.2 Function of the Renal System
- •15.2 Susceptibility of the Renal System
- •15.3 Examples of Nephrotoxicants
- •15.3.1 Metals
- •15.3.2 Aminoglycosides
- •15.3.3 Amphotericin B
- •15.3.4 Chloroform
- •15.3.5 Hexachlorobutadiene
- •Suggested Reading
- •16 Toxicology of the Nervous System
- •16.1 Introduction
- •16.2 The Nervous system
- •16.2.1 The Neuron
- •16.2.2 Neurotransmitters and their Receptors
- •16.2.3 Glial Cells
- •16.3 Toxicant Effects on the Nervous System
- •16.3.1 Structural Effects of Toxicants on Neurons
- •16.3.2 Effects of Toxicants on Other Cells
- •16.4 Neurotoxicity Testing
- •16.4.1 In vivo Tests of Human Exposure
- •16.4.2 In vivo Tests of Animal Exposure
- •16.4.3 In vitro Neurochemical and Histopathological End Points
- •16.5 Summary
- •Suggested Reading
- •17 Endocrine System
- •17.1 Introduction
- •17.2 Endocrine System
- •17.2.1 Nuclear Receptors
- •17.3 Endocrine Disruption
- •17.3.1 Hormone Receptor Agonists
- •17.3.2 Hormone Receptor Antagonists
- •17.3.3 Organizational versus Activational Effects of Endocrine Toxicants
- •17.3.4 Inhibitors of Hormone Synthesis
- •17.3.5 Inducers of Hormone Clearance
- •17.3.6 Hormone Displacement from Binding Proteins
- •17.4 Incidents of Endocrine Toxicity
- •17.4.1 Organizational Toxicity
- •17.4.2 Activational Toxicity
- •17.4.3 Hypothyroidism
- •17.5 Conclusion
- •Suggested Reading
- •18 Respiratory Toxicity
- •18.1 Introduction
- •18.1.1 Anatomy
- •18.1.2 Cell Types
- •18.1.3 Function
- •18.2 Susceptibility of the Respiratory System
- •18.2.1 Nasal
- •18.2.2 Lung
- •18.3 Types of Toxic Response
- •18.3.1 Irritation
- •18.3.2 Cell Necrosis
- •18.3.3 Fibrosis
- •18.3.4 Emphysema
- •18.3.5 Allergic Responses
- •18.3.6 Cancer
- •18.3.7 Mediators of Toxic Responses
- •18.4 Examples of Lung Toxicants Requiring Activation
- •18.4.1 Introduction
- •18.4.2 Monocrotaline
- •18.4.3 Ipomeanol
- •18.4.4 Paraquat
- •18.5 Defense Mechanisms
- •Suggested Reading
- •19 Immunotoxicity
- •19.1 Introduction
- •19.2 The Immune System
- •19.3 Immune Suppression
- •19.4 Classification of Immune-Mediated Injury (Hypersensitivity)
- •19.5 Effects of Chemicals on Allergic Disease
- •19.5.1 Allergic Contact Dermatitis
- •19.5.2 Respiratory Allergens
- •19.5.3 Adjuvants
- •19.6 Emerging Issues: Food Allergies, Autoimmunity, and the Developing Immune System
- •Suggested Reading
- •20 Reproductive System
- •20.1 Introduction
- •20.2 Male Reproductive Physiology
- •20.3 Mechanisms and Targets of Male Reproductive Toxicants
- •20.3.1 General Mechanisms
- •20.3.2 Effects on Germ Cells
- •20.3.3 Effects on Spermatogenesis and Sperm Quality
- •20.3.4 Effects on Sexual Behavior
- •20.3.5 Effects on Endocrine Function
- •20.4 Female Reproductive Physiology
- •20.5 Mechanisms and Targets of Female Reproductive Toxicants
- •20.5.1 Tranquilizers, Narcotics, and Social Drugs
- •20.5.2 Endocrine Disruptors (EDs)
- •20.5.3 Effects on Germ Cells
- •20.5.4 Effects on the Ovaries and Uterus
- •20.5.5 Effects on Sexual Behavior
- •Suggested Reading
- •21 Toxicity Testing
- •21.1 Introduction
- •21.2 Experimental Administration of Toxicants
- •21.2.1 Introduction
- •21.2.2 Routes of Administration
- •21.3 Chemical and Physical Properties
- •21.4 Exposure and Environmental Fate
- •21.5 In vivo Tests
- •21.5.1 Acute and Subchronic Toxicity Tests
- •21.5.2 Chronic Tests
- •21.5.3 Reproductive Toxicity and Teratogenicity
- •21.5.4 Special Tests
- •21.6 In vitro and Other Short-Term Tests
- •21.6.1 Introduction
- •21.6.2 Prokaryote Mutagenicity
- •21.6.3 Eukaryote Mutagenicity
- •21.6.4 DNA Damage and Repair
- •21.6.5 Chromosome Aberrations
- •21.6.6 Mammalian Cell Transformation
- •21.6.7 General Considerations and Testing Sequences
- •21.7 Ecological Effects
- •21.7.1 Laboratory Tests
- •21.7.2 Simulated Field Tests
- •21.7.3 Field Tests
- •21.8 Risk Analysis
- •21.9 The Future of Toxicity Testing
- •Suggested Reading
- •22 Forensic and Clinical Toxicology
- •22.1 Introduction
- •22.2 Foundations of Forensic Toxicology
- •22.3 Courtroom Testimony
- •22.4.1 Documentation Practices
- •22.4.2 Considerations for Forensic Toxicological Analysis
- •22.4.3 Drug Concentrations and Distribution
- •22.5 Laboratory Analyses
- •22.5.1 Colorimetric Screening Tests
- •22.5.2 Thermal Desorption
- •22.5.6 Enzymatic Immunoassay
- •22.6 Analytical Schemes for Toxicant Detection
- •22.7 Clinical Toxicology
- •22.7.1 History Taking
- •22.7.2 Basic Operating Rules in the Treatment of Toxicosis
- •22.7.3 Approaches to Selected Toxicoses
- •Suggested Reading
- •23 Prevention of Toxicity
- •23.1 Introduction
- •23.2 Legislation and Regulation
- •23.2.1 Federal Government
- •23.2.2 State Governments
- •23.2.3 Legislation and Regulation in Other Countries
- •23.3 Prevention in Different Environments
- •23.3.1 Home
- •23.3.2 Workplace
- •23.3.3 Pollution of Air, Water, and Land
- •23.4 Education
- •Suggested Reading
- •24 Human Health Risk Assessment
- •24.1 Introduction
- •24.2 Risk Assessment Methods
- •24.2.2 Exposure Assessment
- •24.2.3 Dose Response and Risk Characterization
- •24.3 Noncancer Risk Assessment
- •24.3.1 Default Uncertainty and Modifying Factors
- •24.3.2 Derivation of Developmental Toxicant RfD
- •24.3.3 Determination of RfD and RfC of Naphthalene with the NOAEL Approach
- •24.3.4 Benchmark Dose Approach
- •24.3.5 Determination of BMD and BMDL for ETU
- •24.3.6 Quantifying Risk for Noncarcinogenic Effects: Hazard Quotient
- •24.3.7 Chemical Mixtures
- •24.4 Cancer Risk Assessment
- •24.5 PBPK Modeling
- •Suggested Reading
- •25 Analytical Methods in Toxicology
- •25.1 Introduction
- •25.2 Chemical and Physical Methods
- •25.2.1 Sampling
- •25.2.2 Experimental Studies
- •25.2.3 Forensic Studies
- •25.2.4 Sample Preparation
- •25.2.6 Spectroscopy
- •25.2.7 Other Analytical Methods
- •Suggested Reading
- •26 Basics of Environmental Toxicology
- •26.1 Introduction
- •26.2 Environmental Persistence
- •26.2.1 Abiotic Degradation
- •26.2.2 Biotic Degradation
- •26.2.3 Nondegradative Elimination Processes
- •26.3 Bioaccumulation
- •26.4 Toxicity
- •26.4.1 Acute Toxicity
- •26.4.2 Mechanisms of Acute Toxicity
- •26.4.3 Chronic Toxicity
- •26.4.5 Abiotic and Biotic Interactions
- •26.5 Conclusion
- •Suggested Reading
- •27.1 Introduction
- •27.2 Sources of Toxicants to the Environment
- •27.3 Transport Processes
- •27.3.1 Advection
- •27.3.2 Diffusion
- •27.4 Equilibrium Partitioning
- •27.5 Transformation Processes
- •27.5.1 Reversible Reactions
- •27.5.2 Irreversible Reactions
- •27.6 Environmental Fate Models
- •Suggested Reading
- •28 Environmental Risk Assessment
- •28.1 Introduction
- •28.2 Formulating the Problem
- •28.2.1 Selecting Assessment End Points
- •28.2.2 Developing Conceptual Models
- •28.2.3 Selecting Measures
- •28.3 Analyzing Exposure and Effects Information
- •28.3.1 Characterizing Exposure
- •28.3.2 Characterizing Ecological Effects
- •28.4 Characterizing Risk
- •28.4.1 Estimating Risk
- •28.4.2 Describing Risk
- •28.5 Managing Risk
- •Suggested Reading
- •29 Future Considerations for Environmental and Human Health
- •29.1 Introduction
- •29.2 Risk Management
- •29.3 Risk Assessment
- •29.4 Hazard and Exposure Assessment
- •29.5 In vivo Toxicity
- •29.6 In vitro Toxicity
- •29.7 Biochemical and Molecular Toxicology
- •29.8 Development of Selective Toxicants
- •Glossary
- •Index
236 CHEMICAL CARCINOGENESIS
Table 12.4 Carcinogen Classification System of the National Toxicology Program
Known to be a human carcinogen
There is sufficient evidence of carcinogenicity from studies in humans which indicates a causal relationship between exposure to the agent, substance, or mixture and human cancer.
Reasonably anticipated to be a human carcinogen
There is limited evidence of carcinogenicity from studies in humans which indicates a causal interpretation is credible, but alternate explanations, such as chance, bias, or confounding factors, cannot adequately be excluded;
or
There is sufficient evidence of carcinogenicity from studies in experimental animals which indicates there is an increased incidence of malignant and/or a combination of malignant and benign tumors: (1) in multiple species or at multiple tissue sites, or (2) by multiple routes of exposure, or (3) to an unusual degree with regard to incidence, site, or type of tumor, and age at onset;
or
There is less than sufficient evidence of carcinogenicity in humans or laboratory animals, however the agent, substance or mixture belongs to a well defined, structurally-related class of substances whose members are listed in a previous Report on Carcinogens as either a known to be human carcinogen or reasonably anticipated to be human carcinogen, or there is convincing relevant information that the agent acts through mechanisms indicating that it would likely cause cancer in humans.
Conclusions regarding carcinogenicity in humans or experimental animals are based on scientific judgment, with consideration given to all relevant information. Relevant information includes, but is not limited to, dose response, route of exposure, chemical structure, metabolism, pharmacokinetics, sensitive subpopulations, genetic effects, and other data relating to mechanism of action or factors that may be unique to a given substance. For example, there may be a substance for which there is evidence of carcinogenicity in laboratory animals but there are compelling data indicating that the agent acts through mechanisms that do not operate in humans and it would therefore not reasonably be anticipated to cause cancer in humans.
Source: From the Tenth Report on Carcinogens, US Department of Health and Human Services, Public Health Service, National Toxicology Program.
12.3CLASSES OF AGENTS ASSOCIATED WITH CARCINOGENESIS
Chemical agents that influence cancer development can be divided into two major categories based on whether or not they are mutagenic in in vitro mutagenicity assay. DNA-damaging agents (genotoxic) are mutagenic in in vitro mutagenicity assays and are considered to produce permanent alterations in the genetic material of the host in vivo, and epigenetic agents (nongenotoxic) are not mutagenic in in vitro assays. These agents are not believed to alter the primary sequence of DNA but are considered to alter the expression or repression of certain genes and/or to produce perturbations in signal transduction pathways that influence cellular events related to proliferation, differentiation, or apoptosis. Many epigenetic/nongenotoxic agents contribute to the clonal expansion of cells containing an altered genotype (DNA alterations) to form tumors, however in the absence of such DNA alterations these epigenetic agents have no effect on tumor formation.
|
|
CLASSES OF AGENTS ASSOCIATED WITH CARCINOGENESIS |
237 |
Table 12.5 IARC and EPA Classification of Carcinogens |
|
||
|
|
|
|
IARC |
EPA |
|
|
|
|
|
|
1 |
Group A |
Human carcinogens |
|
|
|
Sufficient evidence from epidemiological studies to support a causal |
|
|
|
association between exposure to the agents and cancer |
|
2A |
Group B |
Probable human carcinogens |
|
|
Group B1 |
Limited epidemiological evidence that the agent causes cancer regardless |
|
|
|
of animal data |
|
|
Group B2 |
Inadequate epidemiological evidence or no human data on the |
|
|
|
carcinogenicity of the agent and sufficient evidence in animal studies |
|
|
|
that the agent is carcinogenic |
|
2B |
Group C |
Possible human carcinogens |
|
|
|
Absence of human data with limited evidence of carcinogenicity in |
|
|
|
animals |
|
3 |
Group D |
Not classifiable as to human carcinogenicity |
|
|
|
Agents with inadequate human and animal evidence of carcinogenicity or |
|
|
|
for which no data are available |
|
4 |
Group E |
Evidence of noncarcinogenicity for humans |
|
|
|
Agents that show no evidence for carcinogenicity in at least two adequate |
|
|
|
animal tests in different species or in both adequate epidemiologic and |
|
|
|
animal studies |
|
|
|
|
|
12.3.1DNA-Damaging Agents
DNA-damaging agents can be divided into four major categories. (1) Directacting carcinogens are intrinsically reactive compounds that do not require metabolic activation by cellular enzymes to covalently interact with DNA. Examples include N-methyl-N-nitrosourea and N-methyl-N -nitro-N-nitrosoguanidine; the alkyl alkanesulfonates such as methyl methanesulfonate; the lactones such as beta propiolactone and the nitrogen and sulfur mustards. (2) Indirect-acting carcinogens require metabolic activation by cellular enzymes to form the ultimate carcinogenic species that covalently binds to DNA. Examples include dimethylnitrosamine, benzo[a]pyrene, 7,12-dimethylbenz[a]anthracene, aflatoxin B1 and 2-acetylaminofluorene (Figure 12.8). (3) Radiation and oxidative DNA damage can occur directly or indirectly. Ionizing radiation produces DNA damage through direct ionization of DNA to produce DNA strand breaks or indirectly via the ionization of water to reactive oxygen species that damage DNA bases. Ultraviolet radiation (UVR) from the sun is responsible for approximately 1 million new cases of human basal and squamous cell skin cancer each year. Reactive oxygen species can also be produced by various chemicals and cellular process including respiration and lipid peroxidation. (4) Inorganic agents such as arsenic, chromium and nickel are considered DNA-damaging agents although in many cases the definitive mechanism is unknown. DNA-damaging agents can produce three general types of genetic alterations: (1) gene mutations, which include point mutations involving single base pair substitutions that can result in amino acid substitutions in the encoded protein, and frame shift mutations
238 |
CHEMICAL CARCINOGENESIS |
|
|
|
|
|
||
Procarcinogen |
|
Proximate |
Putative |
|||||
|
|
|
Carcinogen |
Ultimate |
||||
|
|
|
|
Carcinogen |
||||
H3C |
|
|
|
H3C |
||||
|
N N |
|
O |
N |
|
N |
|
O |
|
|
|
|
|||||
H3C |
|
|
|
H |
||||
Dimethylnitrosamine |
|
|
|
|
|
|
|
|
|
|
|
O |
|
|
O |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N |
C |
|
CH3 |
|
|
C |
|
CH3 |
||
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
H |
|
|
N |
|||||||
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
OH |
|||||||
|
|
CH2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
2-Acetylaminofluorene (AAF) |
N-Hydroxy-AAF |
||||||||||||||
|
|
|
|
O |
|
O |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
O |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
O |
O |
|
|
OCH3 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||
Aflatoxin B1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
9 |
|
|
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
8 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
7 |
|
5 |
|
|
|
|
|
|
O 7 |
||||||
Benzo(a)pyrene (BP) |
|
|
|
|
|
|
BP-7, 8-epoxide |
HO
OH
BP-7, 8-dihydro-7, 8-diol
O
C CH3
N
OSO3−
Sulfate ester Of
N-hydroxy-AAF
3
O
2 O
Aflatoxin B1 2, 3-epoxide
O 10
9
HO
OH
BP-7, 8-dihydro-7, 8- diol-9, 10-epoxide
Figure 12.8 Examples of DNA-damaging carcinogens.
involving the loss or gain of one or two base pairs, resulting in an altered reading frame and gross alterations in the encoded protein; (2) chromosome aberrations, including gross chromosomal rearrangement such as deletions, duplications, inversions, and translocations; and (3) aneuploidy and polyploidy, which involve the gain or loss of one or more chromosomes.
CLASSES OF AGENTS ASSOCIATED WITH CARCINOGENESIS |
239 |
12.3.2Epigenetic Agents
Epigenetic agents that influence carcinogenesis are not thought to alter the primary sequence of DNA, but rather they are considered to alter the expression or repression of certain genes and/or produce perturbations in signal transduction pathways that influence cellular events related to proliferation, differentiation, or apoptosis. Many epigenetic agents favor the proliferation of cells with an altered genotype (cells containing a mutated oncogene(s) and/or tumor suppressor gene(s)) and allow the clonal expansion of these altered or “initiated” cells. Epigenetic agents can be divided into four major categories: (1) hormones such as conjugated estrogens and diethylstilbestrol;
(2) immunosuppressive xenobiotics such as azathioprine and cyclosporin A; (3) solid state agents, which include plastic implants and asbestos; and (4) tumor promoters in rodent models, which include 12-O-tetradecanoylphorbol-13-acetate, peroxisome proliferators, TCDD and phenobarbital (Figure 12.9). In humans, diet (including caloric,
|
Cl |
|
|
|
O |
|
|
|
|
|
Cl |
||
|
|
|
|
|
|
|
|
|
|
||||
|
Cl |
|
|
O |
|
|
|
|
|
Cl |
|||
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin |
||||||||||||
|
|
|
|
|
|
|
|
|
Cl |
||||
|
|
|
|
H |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N |
|
|
N |
||||||
|
|
|
|
|
|
N |
|
|
|
|
|
|
|
CH3 |
|
|
S |
|
CH2 |
|
COOH |
||||||
|
|
|
|
|
|||||||||
|
|
|
|
||||||||||
|
|
|
|
|
|
Wy-14,643 |
H
N
O C C O
H5C2 C NH
C
O
Phenobarbital
|
|
|
|
|
|
H3C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CH3 |
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
COOH |
||||
|
|
|
CH3 |
H |
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
H |
H |
|
|
|
|
|
|
|
|
|
|
|
|
HO |
H |
OH |
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
Cholic acid |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
CH3 |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
O |
|
C |
|
COOH |
|||||||
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nafenopin |
|
|
CH3 |
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
O |
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C(CH2)12 |
|
|
|
CH3 |
||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
O |
|
|
||||
|
|
|
|
H |
O |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C |
|
|
|
CH3 |
||||||
|
|
|
H3C |
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
O |
|
|
||||||||||
|
|
H |
H |
|
|
|
|
|
|
CH3 |
|||||||
|
|
HO |
|
|
|
|
|
|
|||||||||
|
|
|
H |
|
|
|
|
|
CH3 |
|
|
||||||
|
|
|
|
|
|
|
|
H |
|
|
|||||||
I3C |
|
|
|
|
|
H |
|
|
|||||||||
|
O |
HO |
CH2OH |
|
|
||||||||||||
|
H H |
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tetradecanoyl phorbol acetate (TPA)
Figure 12.9 Examples of tumor promoters.
- #15.08.20134.04 Mб14Hastie T., Tibshirani R., Friedman J. - The Elements of Statistical Learning Data Mining, Inference and Prediction (2002)(en).djvu
- #
- #
- #
- #
- #
- #
- #
- #15.08.201315.44 Mб23Hudlicky M, Pavlath A.E. (eds.) - Chemistry of Organic Fluorine Compounds 2[c] A critical Review (1995)(en).djvu
- #
- #